Supriya Lifescience Share Price
Small Cap | Pharmaceuticals and health care | NSE: SUPRIYA | BSE: 543434
₹709.65 -85.45 (-10.75 %)
Last Updated: 04 Apr 2025 03:59 PM
Overview
Open (₹) 787.90
High (₹) 787.90
Low (₹) 686.55
Prev. Close (₹) 795.10
Volume 10,84,540
VWAP (₹) 600.84
ROCE (%) 19.87
Industry P/E 44.73
TTM P/E 32.73
P/B Ratio 7.00
Market Cap (₹) Cr.5,711.46
Dividend Yield (%)0.11
EPS (₹) 14.80
ROE14.61%
Sales Growth (%) 23.74
Profit Growth (%)32.56
Day Range
787.90787.90
52 Week Range
330.50841.70
Historical Returns
Returns (6M)
32.42 %
Returns (1Y)
85.55 %
Returns (3Y)
41.83 %
Returns (5Y)
81.57 %
Returns (6M)
32.42 %
Returns (1Y)
85.55 %
Returns (3Y)
41.83 %
Returns (5Y)
81.57 %
SWOT Analysis
- Increasing Revenue every Quarter for the past 4 Quarters
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
RSI 46.78
MFI 13.90
ATR 45.06
Commodity Channel Index -129.63
ROC125 9.31
ROC21 -16.55
Williams %R -94.31
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 620.80 | 644.20 | 661.80 | 603.20 | 579.80 | 562.20 | 538.80 |
Week Ago | 672.69 | 705.52 | 725.19 | 653.02 | 620.19 | 600.52 | 567.69 |
Month Ago | 664.31 | 703.98 | 728.11 | 640.18 | 600.51 | 576.38 | 536.71 |
EMA & SMA
709.65
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 633.48
9 Day 638.56
10 Day 645.10
12 Day 657.33
14 Day 666.96
20 Day 688.30
26 Day 685.88
50 Day 703.54
100 Day 678.78
200 Day 568.63
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 22 Nov, 2024 | ₹785.02 | 5,85,068 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 22 Nov, 2024 | ₹784.79 | 5,85,068 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 12 Aug, 2024 | ₹488.61 | 6,58,285 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 12 Aug, 2024 | ₹488.59 | 6,58,285 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 08 Feb, 2024 | ₹342.32 | 6,27,793 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 08 Feb, 2024 | ₹342.21 | 6,27,793 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 26 Dec, 2023 | ₹312.40 | 4,56,665 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 26 Dec, 2023 | ₹312.26 | 4,56,665 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 12 May, 2023 | ₹248.48 | 4,03,147 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 12 May, 2023 | ₹248.38 | 4,03,147 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
28 Feb, 2024 | Shivani Satish Wagh | Acquisition | ₹ | 73,125 | NSE |
28 Feb, 2024 | Saloni Satish Wagh | Disposal | ₹ | 73,125 | NSE |
03 Apr, 2023 | Satish Waman Wagh | Acquisition | ₹190.22 | 13,000 | NSE |
31 Mar, 2023 | Satish Waman Wagh | Acquisition | ₹177.79 | 14,000 | NSE |
06 Mar, 2023 | Satish Waman Wagh | Acquisition | ₹203.69 | 2,000 | NSE |
06 Mar, 2023 | Satish Waman Wagh | Acquisition | ₹203.69 | 8,000 | NSE |
02 Mar, 2023 | Satish Waman Wagh | Acquisition | ₹198.06 | 2,000 | NSE |
02 Mar, 2023 | Satish Waman Wagh | Acquisition | ₹198.06 | 8,000 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
28 May, 2024 | Rs.0.8000 per share(40%)Final Dividend | 20 Sept, 2024 | 01 Jan, 1970 |
26 May, 2023 | Rs.0.6000 per share(30%)Final Dividend | 15 Sept, 2023 | 01 Jan, 1970 |
20 May, 2022 | Rs.0.6000 per share(30%)Final Dividend | 01 Sept, 2022 | 01 Jan, 1970 |
Announcements
Date | Source | Detail |
---|---|---|
01 Apr, 2025 | BSE India | Enclosed herewith details of Analyst/Institutional Investor Meetings. |
01 Apr, 2025 | NSE India | Enclosed herewith details of Analyst/Institutional Investor Meetings. |
26 Mar, 2025 | NSE India | Supriya Lifescience Limited has informed the Exchange about Closure of Trading Window |
26 Mar, 2025 | NSE India | Supriya Lifescience Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
25 Mar, 2025 | NSE India | Supriya Lifescience Limited has informed the Exchange about Copy of Newspaper Publication for Postal Ballot |
24 Mar, 2025 | NSE India | Supriya Lifescience Limited has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot |
24 Mar, 2025 | NSE India | Supriya Lifescience Limited has informed the Exchange regarding Notice of Postal Ballot |
24 Mar, 2025 | BSE India | Please find attached Postal Ballot Notice of Supriya Lifesciences Limited |
17 Mar, 2025 | NSE India | Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, the details of the Analyst/Investor Meetings to be attended by the Company are as enclosed herewith. |
17 Mar, 2025 | BSE India | Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, the details of the Analyst/ Investor Meetings to be attended by the Company are enclosed herewith. |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Others | Inter-alia, to consider 1. Appointment of Company Secretary and Compliance Officer of the Company. 2. Other business matters. | 06 Mar, 2025 | 10 Mar, 2025 |
Quarterly Results & Others | To consider other business matters. | 20 Jan, 2025 | 24 Jan, 2025 |
Quarterly Results | -- | 22 Oct, 2024 | 28 Oct, 2024 |
Quarterly Results | -- | 06 Aug, 2024 | 10 Aug, 2024 |
Audited Results & Final Dividend | -- | 22 May, 2024 | 28 May, 2024 |
Quarterly Results | -- | 31 Jan, 2024 | 07 Feb, 2024 |
Quarterly Results | -- | 30 Oct, 2023 | 07 Nov, 2023 |
Quarterly Results | -- | 28 Jul, 2023 | 03 Aug, 2023 |
Audited Results & Final Dividend | -- | 22 May, 2023 | 26 May, 2023 |
Quarterly Results | -- | 07 Feb, 2023 | 14 Feb, 2023 |
Share Holding Pattern
Owner Name | Sept, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | |
---|---|---|---|---|---|
Promoter Group | 68.3% | 68.3% | 68.24% | 68.24% | 0% |
Foreign Institutions + | 6.03% | 4.56% | 6.24% | 10.3% | 0% |
Domestic Institutions + | 5.45% | 5.39% | 7.89% | 7.9% | 0% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 20.22% | 21.75% | 17.63% | 13.56% | 0% |
Others | 0% | 0% | 0% | 0% | 0% |
About Supriya Lifescience
Supriya Lifescience is a Public Limited Listed company incorporated on 26/03/2008 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH2008PLC180452 and registration number is 180452. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 570.37 Cr. and Equity Capital is Rs. 16.10 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
2008
Managing Director
-- --
NSE Symbol
SUPRIYA
Supriya Lifescience Management
Name | Designation |
---|---|
Mr. Satish Waman Wagh | Exe.Chairman & W T D |
Ms. Smita Satish Wagh | Whole Time Director |
Ms. Saloni Satish Wagh | Whole Time Director |
Ms. Shivani Satish Wagh | Whole Time Director |
Mr. Balasahab Gulabrao Sawant | Whole Time Director |
Mr. Kedar Shankar Karmarkar | Independent Director |
Mr. Bhairav Manojbhai Chokshi | Independent Director |
Mr. Dileep Kumar Jain | Independent Director |
Mr. Dinesh Navnitlal Modi | Independent Director |
Ms. Neelam Yashpal Arora | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35 ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50 ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Supriya Lifescience
What is the share price of Supriya Lifescience?
The share price of Supriya Lifescience on 04 Apr, 2025 is ₹ 709.65.
What is 52W high and 52W low share price of Supriya Lifescience?
The highest and lowest 52W share prices of Supriya Lifescience are ₹ 841.700 and ₹ 330.500
What is the market cap of Supriya Lifescience?
The market capitalization of Supriya Lifescience as of 04 Apr, 2025 is ₹ 5,711.46 Crores
What is the P/E ratio of Supriya Lifescience?
The current P/E ratio of Supriya Lifescience as of 04 Apr, 2025 is 44.73
What is the PB ratio of Supriya Lifescience?
The PB ratio of Supriya Lifescience as of 04 Apr, 2025 is 7.00
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)